Celgene (CELG) Receives EC Approval of ABRAXANE Combo as First-Line NSCLC Treatment
Tweet Send to a Friend
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (Nasdaq: CELG), today announced that the European Commission (EC) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE